SCHEMBL8267992

SCHEMBL8267992

Cc1ccc(-c2nc3ccc(C)cn3c2CNC(=O)c2cc(C)on2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.53
GABRB2 P47870 3/20 0.53
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
ALB P02768 1/20 0.53
CYP3A4 P08684 1/20 0.53
CHRM1 P11229 1/20 0.53
HPGD P15428 1/20 0.53
GABRB1 P18505 1/20 0.53
GABRG2 P18507 1/20 0.53
GABRB3 P28472 1/20 0.53
GABRA3 P34903 1/20 0.53
ADRA1A P35348 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR2B P41595 1/20 0.53
GABRA2 P47869 1/20 0.53
KCNH2 Q12809 1/20 0.53
HSD17B10 Q99714 1/20 0.53
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8288575 0.84 GABRA1 (0.61) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL8268011 0.82 GABRA1 (0.52) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL13970098 0.82 GABRA1 (0.52) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL13970090 0.82 GABRA1 (0.54) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL8266201 0.81 GABRA1 (0.53) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL8266611 0.81 GABRA1 (0.53) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL8267987 0.81 GABRA1 (0.53) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL4262267 0.81 KDM4E (0.60) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL8267113 0.80 SMN1; SMN2 (0.57) GABRA1GABRB2KDM4ELMNAALB
SCHEMBL4408422 0.80 GABRA1 (0.52) GABRA1GABRB2KDM4ELMNAALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814880-B1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INT (ES) 2009-01-28 EP disclosed
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto FERRER INTERNACIONAL, S.A. (ES) 2008-08-21 US disclosed
WO-2006051063-A1 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO FERRER INTERNACIONAL S. A. (ES) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200473-A1 Imidazo [1,2-a]Pyridine Compounds, Compositions, Uses and Methods Thereto GABRA1, GABRA2, GABRA3 GABRA1 1/4885GABRB2 5/4885KDM4E 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.